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 Adipose tissue distribution is effective in metabolic complications resulting 
from obesity. Fat accumulation in the body, particularly increase in visceral 
fat, is a major risk factor of diabetes and cardiovascular diseases. The present 
study aimed to determine the prevalence of obesity and android obesity based 
on various phenotypes of Polycystic Ovarian Syndrome (PCOS) in 14-18 
year old high-school girl students in Shiraz in 2009. This descriptive study 
was conducted on 14-18 year old high-school girl students in Shiraz in 2009. 
Considering the confidence coefficient of 95% and loss rate of 20%, a 3190-
subject sample size was determined for the study. The participants were 
selected through purposive sampling. After obtaining written informed 
consents, demographic information questionnaire was completed and the 
participants were examined regarding hirsutism, acne, alopecia, and 
menstrual disorders. Besides, the criteria proposed by Adams et al. were 
employed to diagnose PCOS in sonography. Android obesity and Body Mass 
Index (BMI) were evaluated, as well. The results of independent t-test 
showed no significant difference among various phenotypes of PCOS 
regarding mean android obesity and BMI (P>0.05). The results of the present 
study revealed no significant relationship between girl adolescents' obesity 
and various phenotypes of PCOS. However, adolescents should be informed 
about the long-term hyperandrogenic outcomes which are accompanied by 
insulin secretion and endanger their health after the age of 40 years. 
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1. INTRODUCTION 
In Europe, Polycystic Ovarian Syndrome (PCOS) is diagnosed by existence of cystic ovaries in 
sonography together with oligomenorrhea, hyperandrogenism, obesity, or increase of serum LH or 
testosterone. In the U.S., on the other hand, National Institute Health (NIH) in 1990 suggested 
hyperandrogenism or hyperandrogenemia and ovulatory dysfunction in the absence of non-classical adrenal 
hyperplasia as the diagnostic criteria for PCOS [1]. PCOS is mainly accompanied by oligomenorrhea or 
amenorrhea and is identified by the clinical or laboratory indications of hyperandrogenemia. Therefore, the 
prevalence rate of PCOS is varied from 6% to 22% in different parts of the world [2],[3] and the difference in 
statistics results from different criteria used for diagnosis of this syndrome [4]. Nowadays, it has been shown 
that a large number of obese women with PCOS suffer from hyperinsulinemia, as well [5]. Moreover, many 
adolescents suffering from PCOS are overweight or obese. It seems that PCOS is the endocrine cause of 
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obesity in girl adolescents [6]. Recent systematic studies have shown that PCOS can result from the same 
genetic factors which lead to obesity in women. Yet, it is not known whether obesity is the primary factor in 
the incidence of PCOS or vice versa. Overall, the women with PCOS are more obese abdominally compared 
to those with similar weight and Body Mass Index (BMI) [7]. Even non-obese PCOS adolescents have twice 
as much abdominal fat as the general population [8]. Android obesity is highly correlated to 
hyperandrogenism and BMI is correlated to insulin resistance [9]. 
The results of the study by Trent (2002) showed that weight problems caused stress and anxiety for 
the individuals suffering from PCOS. Hence, psychological problems and difficulty in determining one's 
health and identity is another important dimension of this syndrome. Evidence has shown that adult females 
with PCOS normally suffer from infertility and its outcomes, while such adolescents are more concerned 
with weight gain, menstrual disorders, acne, and hirsutism. These complications seriously affect young girls' 
quality of life. Therefore, young adults suffering from this syndrome must be diagnosed and treated as soon 
as possible. 
 
 
2. MATERIALS AND METHODS 
This descriptive study was conducted on 14-18 year old high-school girl students in Shiraz in 2009. 
Based on a similar study performed in Isfahan [10] and considering the confidence coefficient of 95% and 
loss rate of 20%, a 3190-subject sample size was determined for the study. Then, 600-800 students were 
selected from each educational district using purposive sampling. The inclusion criteria of the study were 
being 14-18 years old and not consuming any hormones and medications except for anti-allergy and 
analgesic drugs. On the other hand, the exclusion criteria of the study were passage of less than 2 years from 
menarche, having adrenal or thyroid problems, suffering from hyperprolactinemia, primary amenorrhea, 
serious underlying diseases, such as malignancies and thalassemia, which affect menstrual cycles, and having 
identified endocrinopathies, such as Cushing syndrome. 
After obtaining written informed consents, demographic information questionnaire was completed 
and the participants were examined regarding hirsutism, acne, alopecia, and menstrual disorders. Besides, the 
criteria proposed by Adams et al. were utilized to diagnose PCOS in sonography [11]. The participants' waist 
circumference was measured as the distance between the last rib and the iliac crest at the end of expiration in 
standing position. In order to determine android obesity, based on waist circumference and age, 
percentiles>90 were considered as android obesity [12],[13]. 
In order to compute BMI, at first, the participants' height was measured without shoes using a tape 
meter installed on the wall 40 cm higher than the ground level. In doing so, the participants were asked to 
stick their back of head, waist, hip, and feet to the wall and their height was determined by placing a ruler on 
their head. Then, the participants' weight was measured barefoot with the least amount of clothing using 
CAMRY scale (made in China) which was previously adjusted by standard weights [14]. 
BMI charts provided by the Center for Disease Control (CDC) were used to determine underweight, 
overweight, and obesity. Accordingly, 85-95 percentiles were considered as overweight, while percentiles 
>95 were considered as obese [12]. After all, the data were entered into the SPSS statistical software (version 
11.5) and analyzed using Chi-square test. 
 
 
3. RESULTS  
Out of the 41 government high schools in Shiraz, 16 ones took part in the present study. The study 
was conducted on 3190 high-school girl students between 14 and 18 years old in Shiraz. According to the 
results, most of the participants (30.2%) were 17 years old. The participants' mean weight, mean height, and 
mean waist circumference were 54.14+9.99 kg, 160.20+5.76 cm, and 65.24+7.34 cm, respectively. In 
addition, 616 participants (20.5%) were underweight, 234 ones (9.5%) were overweight, and 110 ones (3.5%) 
were obese. Also, 15 participants (0.5%) had android obesity. 
The results of independent t-test revealed no significant difference between the phenotypes of the 
participants with hyperandrogenism and PCOS and those without these disorders, phenotypes of the 
participants with oligomenorrhea and PCOS and those not suffering from these disorders (P=0.41), and 
phenotypes of the participants with oligomenorrhea, PCOS, and hyperandrogenims and those without these 
disorders concerning the mean of android obesity and BMI (P=0.5). 
Overall, 16.6% of the study participants (514 subjects) suffered from menstrual disorders and 
oligomenorrhea. Also, 99 participants (3.1%) had BMI>26. 
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4. DISCUSSIONS 
The results of the present study showed that the prevalence rates of overweight and obesity in Shiraz 
were similar to those reported in developed countries and other parts of Iran. For instance, Salem et al. (2007) 
conducted a study on 11-18 year old girls in Rafsanjan and reported the prevalence rates of overweight and 
obesity to be 11.2% and 2.4%, respectively [15]. In the present study, 9.5% of the participants were 
overweight and 3.5% were obese. One study performed in the U.S. also showed that 16.8% of 2-19 year old 
girls were obese [16]. In another study conducted in Greece, the prevalence rates of overweight and obesity 
were 19% and 2.6%, respectively among 11-17 year old adolescents and these rates were higher among 
males compared to females [17]. The prevalence of obesity is also high in developing countries. In India, for 
example, the prevalence rates of overweight and obesity among 9-15 year old children have been reported to 
be 11.1% and 14.2%, respectively [18]. Hekimsoy (2003) mentioned obesity as an important risk factor of 
type II diabetes, arterial hypertension, and hyperlipidemia. However, contradictory results have been 
obtained regarding the relationship between duration of obesity and these risks [19]. Thus, obesity has been 
considered as a major problem for girls' health in future. 
In the current study, the prevalence of android obesity was 0.5% which was lower compared to the 
measures obtained in the studies performed by Salem and Halley Castillo (2007) [20]. In spite of the fact that 
the prevalence rate of android obesity was low in this study, it is still an alarming issue because according to 
the studies conducted in Asia, android obesity can increase the risk of PCOS by two folds (RR=2.41, P=0.04) 
[4]. It can also increase the incidence rate of metabolic syndrome in future. In fact, android obesity leads to 
resistance in consumption of peripheral glucose and results in hypertension and further metabolic problems 
by causing hyperinsulinemia [21]. The low prevalence of android obesity in the present study might be due to 
the participants' age and sex. In fact, female teenagers are highly concerned about android obesity. 
The results of this study also indicated that the prevalence rates of obesity and android obesity were 
higher in some phenotypes of PCOS. However, no significant difference was observed between the PCOS 
patients and those not suffering from this syndrome in this regard. Of course, this was not unexpected 
because based on the recent systematic review studies conducted on this issue; Asian women are less obese 
compared to the Caucasian women suffering from PCOS [4]. Thus, the incidence of PCOS might also be 
associated with racial factors. Yet, other studies have indicated that almost 25-50% of the women with PCOS 
are obese [22],[23]. These measures have been reported as 10-65% in some studies. Also, a large number of 
adolescents suffering from PCOS are either overweight or obese. In fact, PCOS is the most common 
endocrine cause of obesity in adolescents [24]. In one study, the prevalence of obesity was reported as 27% 
among the adolescents with PCOS [25]. 
The findings of the present study revealed no significant relationship between BMI and menstrual 
patterns. In this study, out of the 16.6% of the participants with menstrual disorders, 3.1% (99) were 
overweight or obese. Evidence has shown that the individuals with oligomenorrhea have higher BMI. 
Sarmeli et al. (2002) also reported high BMI in 19 girls between 16 and 18 years old who suffered from 
oligomenorrhea. Since obesity increases the androgen levels, it is usually accompanied by PCOS and 
oligomenorrhea. Furthermore, irregular and long menstrual cycles might have genetic background, as well. 
Nevertheless, the difference between the results of the present study and those of other studies conducted on 
the issue might be due to the adolescents' nutritional status and their great concern for appropriate waist and 
hip circumference. Of course, since individuals genetically have the disorder, its symptoms are intensified by 
environmental factors and individuals' lifestyles. BMI is one of the main environmental factors which can 
intensify or reduce the severity of the disorder [26]-[29]. 
 
 
5. CONCLUSION 
The results of the present study revealed no significant difference between Iranian girl adolescents 
and those in developed countries regarding the prevalence of obesity. This is an alarming issue for the related 
health organizations. Thus, appropriate educational and social strategies should be suggested for preventing 
this problem, because overweight can lead to metabolic syndrome and PCOS which are serious threats for 
health. Moreover, adolescents should be informed about the long-term hyperandrogenic outcomes which are 
accompanied by insulin secretion and endanger their health after the age of 40 years. The study findings also 
indicated that various phenotypes of PCOS in adolescents were not significantly related to obesity and 
overweight. Therefore, further studies are required to investigate the psychological and genetic causes of the 
incidence of this syndrome. 
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